Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Egalet Corp (EGLT)

0.5066 0.01 (1.91%)

05-22 16:00

Open:

0.5

Pre. Close:

0.4971

High:

0.5098

Low:

0.49

Volume:

313,841

Market Cap:

27M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.51 - 0.513

0.513 - 0.515

Low:

0.484 - 0.487

0.487 - 0.489

Close:

0.505 - 0.51

0.51 - 0.514

Technical analysis  (as of: 2018-05-22 4:38:28 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 0.77     One year: 0.90

Support:

Support1: 0.47    Support2: 0.40

Resistance:

Resistance1: 0.66    Resistance2: 0.77

Pivot:

0.62

Moving Averages:

MA(5): 0.50     MA(20): 0.63

MA(100): 0.78     MA(250): 1.17

MACD:

MACD(12,26): -0.05     Signal(12,26,9): -0.03

%K %D:

%K(14,3): 10.50     %D(3): 9.22

RSI:

RSI(14): 31.78

52-Week:

High: 3.47  Low: 0.475  Change(%): -82.2

Average Vol(K):

3-Month: 89700  10-Days 87033

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
EGLT has closed above bottom band by 20.5%. Bollinger Bands are 78.8% wider than normal. The large width of the bands suggest high volatility as compared to EGLT's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

2018-05-16T16:44:42-04:00
FDA OKs first non-opioid treatment for opioid withdrawal

2018-05-09T17:58:08-04:00
Egalet's (EGLT) CEO Bob Radie on Q1 2018 Results - Earnings Call Transcript

2018-05-08T06:03:50-04:00
Egalet beats by $0.03, misses on revenue

2018-05-08T06:02:00-04:00
Egalet Reports First Quarter 2018 Financial Results

2018-05-07T06:02:00-04:00
Egalet Announces National Pharmacy Benefit Manager to Cover SPRIX® Nasal Spray and ARYMO® ER

2018-04-30T06:02:00-04:00
Egalet Presented Data at American Academy of Pain Medicine Examining the Potential of ARYMO® ER to Deter Opioid Abuse

2018-04-26T03:18:20-04:00
Opioid prescriptions dropped 12% in 2017

2018-04-24T06:02:00-04:00
Egalet to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results on May 8, 2018

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

52.88

Shares Float (M)

51.83

% Held by Insiders

2.00

% Held by Institutions

49.00

Shares Short (K)

4258

Shares Short Prior Month (K)

5320

Stock Financials

EPS

-2.030

EPS Est. Current Year

-2.750

EPS Est. Next Year

-1.150

EPS Est. Next Quarter

-0.410

Forward EPS

-0.692

Book Value (p.s.)

18.340

PEG Ratio

Profit Margin

Operating Margin

-213.54

Return on Assets (ttm)

-59.1

Return on Equity (ttm)

407.4

Qtrly Rev. Growth

15.4

Gross Profit (p.s.)

0.200

Sales Per Share

EBITDA (p.s.)

-0.665

Qtrly Earnings Growth

Operating Cash Flow (M)

Levered Free Cash Flow (M)

atoplab.com

Valuation

P/E

-0.25

P/E Growth Ratio

0.02

P/BV

0.03

P/S

38809968.00

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.